Jeffrey Friedland
Algemeen Directeur bij Friedland Global Capital Pte. Ltd.
Profiel
Jeffrey Friedland is the founder of Israel Plant Sciences Ltd.
(founded in 2015).
He is currently the Chief Executive Officer of Friedland Global Capital Pte.
Ltd.
(since 1979), the Chief Executive Officer of Global Corporate Strategies LLC (since 2011), and a Director at Cannrx Technology, Inc. (current position).
He has previously served as the Chief Executive Officer & Director of Kinder Holding Corp.
and Nexien BioPharma, Inc. He was also a Director at China GengSheng Minerals, Inc. from 2013 to 2014.
Additionally, he has worked as the Managing Director of Friedland Capital Equity Research LLC.
Mr. Friedland obtained his undergraduate degree from The University of Colorado.
Actieve functies van Jeffrey Friedland
| Bedrijven | Functie | Begin |
|---|---|---|
| Friedland Global Capital Pte. Ltd. | Algemeen Directeur | - |
| Global Corporate Strategies LLC | Algemeen Directeur | 01-01-2011 |
Cannrx Technology, Inc.
 Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jeffrey Friedland
| Bedrijven | Functie | Einde |
|---|---|---|
| NEXIEN BIOPHARMA, INC. | Algemeen Directeur | 07-03-2018 |
| CHINA GENGSHENG MINERALS, INC. | Directeur/Bestuurslid | 12-05-2014 |
Israel Plant Sciences Ltd.
 Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Oprichter | - |
Kinder Holding Corp.
 Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Algemeen Directeur | - |
| Friedland Capital Equity Research LLC | President | - |
Opleiding van Jeffrey Friedland
| The University of Colorado | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CHINA GENGSHENG MINERALS, INC. | Non-Energy Minerals |
| NEXIEN BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Kinder Holding Corp.
Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Finance |
| Friedland Capital Equity Research LLC | Finance |
| Friedland Global Capital Pte. Ltd. | |
| Global Corporate Strategies LLC | |
Israel Plant Sciences Ltd.
Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Process Industries |
Cannrx Technology, Inc.
Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Health Technology |
